Brief: Moberg Pharma And Padagis Sign Agreement For MOB-015 In Israel

Moberg Pharma AB (publ)

04/08/2022 07:04

Aug 4 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA AND PADAGIS SIGN AGREEMENT FOR MOB-015 IN
ISRAEL
    * UNDER AGREEMENT PADAGIS IS GRANTED EXCLUSIVE RIGHTS TO
MARKET
AND SELL MOB-015 IN ISRAEL AND PALESTINIAN TERRITORIES.

Source text for Eikon:  ID:nWkr5Z5tJ3 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))